tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CLDX Stock Latest News

Celldex initiated with an Overweight at Morgan Stanley
The FlyCelldex initiated with an Overweight at Morgan Stanley
17d ago
CLDX
Celldex’s Barzolvolimab: Promising Phase 2 Results and Strong Buy Rating
PremiumRatings
Celldex’s Barzolvolimab: Promising Phase 2 Results and Strong Buy Rating
1M ago
CLDX
Celldex presents preclinical data from CDX-622 at AAAAI 2025
PremiumThe Fly
Celldex presents preclinical data from CDX-622 at AAAAI 2025
1M ago
CLDX
Celldex’s Promising Clinical Developments and Strategic Advancements Lead to Buy Rating
PremiumRatings
Celldex’s Promising Clinical Developments and Strategic Advancements Lead to Buy Rating
1M ago
CLDX
Celldex announces data from Phase 2 barzolvolimab studies
PremiumThe Fly
Celldex announces data from Phase 2 barzolvolimab studies
1M ago
CLDX
Celldex: Strong Financial Position and Promising Pipeline Drive Buy Rating
PremiumRatingsCelldex: Strong Financial Position and Promising Pipeline Drive Buy Rating
1M ago
CLDX
Celldex Therapeutics Advances Pipeline Amid Financial Challenges
Premium
Company Announcements
Celldex Therapeutics Advances Pipeline Amid Financial Challenges
1M ago
CLDX
Celldex Buy Rating: Promising Clinical Advancements and Strong Financial Position Drive Positive Outlook
Premium
Ratings
Celldex Buy Rating: Promising Clinical Advancements and Strong Financial Position Drive Positive Outlook
1M ago
CLDX
Celldex reports Q4 EPS (71c), consensus (71c)
PremiumThe Fly
Celldex reports Q4 EPS (71c), consensus (71c)
1M ago
CLDX
Celldex initiated with a Buy at UBS
PremiumThe Fly
Celldex initiated with a Buy at UBS
2M ago
CLDX
Buy Recommendation for Celldex: Barzolvolimab’s Market Leadership and Efficacy Drive Positive Outlook
PremiumRatings
Buy Recommendation for Celldex: Barzolvolimab’s Market Leadership and Efficacy Drive Positive Outlook
2M ago
CLDX
Blueprint Medicines price target lowered to $124 from $135 at Wedbush
PremiumThe Fly
Blueprint Medicines price target lowered to $124 from $135 at Wedbush
3M ago
BPMC
CLDX
Jasper Therapeutics price target lowered to $64 from $90 at BTIG
PremiumThe FlyJasper Therapeutics price target lowered to $64 from $90 at BTIG
3M ago
CLDX
JSPR
JMP Securities healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
3M ago
ALLK
CLDX
Jasper BEACON data ‘net positive,’ says BMO Capital
Premium
The Fly
Jasper BEACON data ‘net positive,’ says BMO Capital
3M ago
CLDX
JSPR
Jasper data alleviates competitive concerns for Celldex, says Citi
PremiumThe Fly
Jasper data alleviates competitive concerns for Celldex, says Citi
3M ago
CLDX
JSPR
Celldex share decline an overreaction, says Cantor Fitzgerald
PremiumThe Fly
Celldex share decline an overreaction, says Cantor Fitzgerald
3M ago
CLDX
Celldex initates Phase 2 study of barzolvolimab in AD
PremiumThe Fly
Celldex initates Phase 2 study of barzolvolimab in AD
4M ago
CLDX
Celldex announces first patient dosed in Phase 1a study of CDX-622
PremiumThe Fly
Celldex announces first patient dosed in Phase 1a study of CDX-622
5M ago
CLDX
Celldex Therapeutics Reports Q3 2024 Progress and Financials
PremiumCompany AnnouncementsCelldex Therapeutics Reports Q3 2024 Progress and Financials
5M ago
CLDX
CLDX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CLDX Upcoming Earnings Report: What to Expect?
5M ago
CLDX
Celldex selloff creates buying opportunity, says Guggenheim
Premium
The Fly
Celldex selloff creates buying opportunity, says Guggenheim
5M ago
CLDX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >